Blog
Optimizing the Impact of Value Analysis with Consistent Evidence
Blog
Drug & Device Insights: Does the evidence support Andexxa’s price premium?
Blog
The AUGUSTUS Study & More: Drug Developments to Watch from ACC19
Blog
TAVR for Low-Risk Patients & More: Device Developments to Watch from ACC19
Blog
Rising Drug Costs: Not Just the Pharmacy Department’s Problem
Blog
Developing a Data-Driven Prioritization Pipeline to Cut Costs and Reduce Variation
Blog
Insights and Perspectives: Orthopedic Robotic Technology
Blog
Insights and Perspectives: Coronary Revascularization Devices
Blog
Geisinger Health: Reducing Variation With Physician Engagement
Blog